BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= 045573
         (535 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
 pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
          Length = 265

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 38  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 95

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 96  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 154

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 155 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 187


>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
 pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
          Length = 264

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
 pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
 pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 260

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 33  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 90

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 91  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 149

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 150 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 182


>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
 pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
          Length = 269

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
 pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
          Length = 268

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
          Length = 262

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 261

 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 34  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 91

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 92  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 150

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 151 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 183


>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
 pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
          Length = 256

 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 29  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 86

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 87  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 145

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 146 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 178


>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
 pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
          Length = 262

 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|1VIN|A Chain A, Bovine Cyclin A3
          Length = 268

 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 35  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 92

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PTI  FL  ++L 
Sbjct: 93  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLAFDLAAPTINQFLTQYFLH 151

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 152 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 184


>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
          Length = 259

 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 32  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 89

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 90  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 148

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 149 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 181


>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
          Length = 260

 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 33  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 90

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 91  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 149

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 150 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 182


>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
 pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
          Length = 258

 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 31  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 88

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 89  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 147

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 148 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 180


>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
 pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
          Length = 261

 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 31  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 88

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y  + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 89  LASKFEEIYPPEVAEFVYITDDTYTKK-QVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLH 147

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPST 496
                        +L  L+L D + +L Y PS 
Sbjct: 148 QQPANCKVESLAMFLGELSLIDADPYLKYLPSV 180


>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
          Length = 261

 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 34  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 91

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y+ + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 92  LASKFEEIYPPEVAEFVYITDDTYSKK-QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLH 150

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPS 495
                        +L  L+L D + +L Y PS
Sbjct: 151 LQPANCKVESLAMFLGELSLIDADPYLKYLPS 182


>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
 pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
          Length = 258

 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 31  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 88

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y+ + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 89  LASKFEEIYPPEVAEFVYITDDTYSKK-QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLH 147

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPS 495
                        +L  L+L D + +L Y PS
Sbjct: 148 LQPANCKVESLAMFLGELSLIDADPYLKYLPS 179


>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
 pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
          Length = 257

 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 359 DLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLA 418
           D+    R+ +V W+VE     K L  ET+ L V+ +DRFLS     ++  LQ+VG A + 
Sbjct: 31  DITNSMRAILVDWLVEVGEEYK-LQNETLHLAVNYIDRFLS-SMSVLRGKLQLVGTAAML 88

Query: 419 LATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTIYNFL-WFYLX 464
           LA++ EE  P             Y+ + +V+ ME LV +VL F    PT+  FL  ++L 
Sbjct: 89  LASKFEEIYPPEVAEFVYITDDTYSKK-QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLH 147

Query: 465 XXXXXXXXXXXXXYLAVLALSDHE-HLSYWPS 495
                        +L  L+L D + +L Y PS
Sbjct: 148 LQPANCKVESLAMFLGELSLIDADPYLKYLPS 179


>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
          Length = 283

 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 61/113 (53%), Gaps = 13/113 (11%)

Query: 363 EQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLALATR 422
           + R+ ++ W++E  C   +LH+ET +L     DR+++     +K  LQ++G++ L +A +
Sbjct: 48  KMRAILLDWLMEV-CEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAAK 106

Query: 423 IEENQP---------YNGRC---EVVAMEWLVQEVLNFQCFLPTIYNFLWFYL 463
           +EE  P          +G C   E++ ME ++ + L ++    TI ++L  Y+
Sbjct: 107 LEEIYPPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSWLNVYM 159


>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
 pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
          Length = 269

 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 62/124 (50%), Gaps = 21/124 (16%)

Query: 350 EYFSGTEY-GDLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRN 408
           +Y  G E  G++    R+ ++ W+V+ Q   + L QETM++ VS++DRF+       K+ 
Sbjct: 26  KYLLGREVTGNM----RAILIDWLVQVQMKFRLL-QETMYMTVSIIDRFMQNNSVP-KKM 79

Query: 409 LQIVGVACLALATRIEENQP-------------YNGRCEVVAMEWLVQEVLNFQCFLPTI 455
           LQ+VGV  + +A++ EE  P             Y  + ++  ME  +   LNF    P  
Sbjct: 80  LQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYT-KHQIRQMEMKILRALNFGLGRPLP 138

Query: 456 YNFL 459
            +FL
Sbjct: 139 LHFL 142


>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
          Length = 260

 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 19/159 (11%)

Query: 350 EYFSGTEY-GDLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRN 408
           +Y  G E  G++    R+ ++ W+V+ Q   + L QETM++ VS++DRF+       K+ 
Sbjct: 24  KYLLGREVTGNM----RAILIDWLVQVQMKFRLL-QETMYMTVSIIDRFMQNNCVP-KKM 77

Query: 409 LQIVGVACLALATRIEENQP------------YNGRCEVVAMEWLVQEVLNFQCFLPTIY 456
           LQ+VGV  + +A++ EE  P               + ++  ME  +   LNF    P   
Sbjct: 78  LQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPL 137

Query: 457 NFLWFYLXXXXXXXXXXXXXXYLAVLALSDHEHLSYWPS 495
           +FL                  YL  L + D++ + + PS
Sbjct: 138 HFLRRASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPS 176


>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 257

 Score = 40.0 bits (92), Expect = 0.004,   Method: Compositional matrix adjust.
 Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 3/81 (3%)

Query: 351 YFSGTEYGDLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQ 410
           YF   +  +++   R  +  W++E  C  ++  +E   L ++ LDRFLS    K K  LQ
Sbjct: 30  YFKCVQ-KEVLPSMRKIVATWMLEV-CEEQKCEEEVFPLAMNYLDRFLSLEPVK-KSRLQ 86

Query: 411 IVGVACLALATRIEENQPYNG 431
           ++G  C+ +A++++E  P   
Sbjct: 87  LLGATCMFVASKMKETIPLTA 107


>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 271

 Score = 39.7 bits (91), Expect = 0.004,   Method: Compositional matrix adjust.
 Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 3/81 (3%)

Query: 351 YFSGTEYGDLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQ 410
           YF   +  +++   R  +  W++E  C  ++  +E   L ++ LDRFLS    K K  LQ
Sbjct: 44  YFKCVQ-KEVLPSMRKIVATWMLEV-CEEQKCEEEVFPLAMNYLDRFLSLEPVK-KSRLQ 100

Query: 411 IVGVACLALATRIEENQPYNG 431
           ++G  C+ +A++++E  P   
Sbjct: 101 LLGATCMFVASKMKETIPLTA 121


>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
 pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
          Length = 306

 Score = 39.3 bits (90), Expect = 0.005,   Method: Compositional matrix adjust.
 Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 2/66 (3%)

Query: 365 RSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLALATRIE 424
           R  + +W++E  C  +   +E   L ++ LDR+LS    + K  LQ++G  C+ LA+++ 
Sbjct: 71  RKMLAYWMLEV-CEEQRCEEEVFPLAMNYLDRYLSCVPTR-KAQLQLLGAVCMLLASKLR 128

Query: 425 ENQPYN 430
           E  P  
Sbjct: 129 ETTPLT 134


>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
           Cyclin
 pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
           Complex With A Flavonol Inhibitor, Fisetin
 pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
           Inhibitor Pd0332991
 pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
           Aminopurvalanol
          Length = 254

 Score = 37.7 bits (86), Expect = 0.016,   Method: Compositional matrix adjust.
 Identities = 20/67 (29%), Positives = 37/67 (55%), Gaps = 2/67 (2%)

Query: 363 EQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLALATR 422
           + R+ ++ W+    C + EL +    L VS+LDR+L +     K+ LQ +G AC+ + ++
Sbjct: 50  DNRTILLTWM-HLLCESFELDKSVFPLSVSILDRYLCKK-QGTKKTLQKIGAACVLIGSK 107

Query: 423 IEENQPY 429
           I   +P 
Sbjct: 108 IRTVKPM 114


>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
          Length = 229

 Score = 37.4 bits (85), Expect = 0.020,   Method: Compositional matrix adjust.
 Identities = 20/66 (30%), Positives = 37/66 (56%), Gaps = 2/66 (3%)

Query: 363 EQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFFKIKRNLQIVGVACLALATR 422
           + R+ ++ W+    C + EL +    L VS+LDR+L +     K+ LQ +G AC+ + ++
Sbjct: 29  DNRTILLTWM-HLLCESFELDKSVFPLSVSILDRYLCKK-QGTKKTLQKIGAACVLIGSK 86

Query: 423 IEENQP 428
           I   +P
Sbjct: 87  IRTVKP 92


>pdb|1Y7Y|A Chain A, High-Resolution Crystal Structure Of The Restriction-
           Modification Controller Protein C.Ahdi From Aeromonas
           Hydrophila
 pdb|1Y7Y|B Chain B, High-Resolution Crystal Structure Of The Restriction-
           Modification Controller Protein C.Ahdi From Aeromonas
           Hydrophila
          Length = 74

 Score = 30.0 bits (66), Expect = 3.0,   Method: Composition-based stats.
 Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 13/86 (15%)

Query: 344 LYDYAEEYFSGTEYGDLIREQRSQMVHWIVEQQCTAKELHQETMFLGVSLLDRFLSRGFF 403
           +  + + Y    ++G  +RE R            TAK L QET+   +S LDR    G  
Sbjct: 1   MQSHHDHYADLVKFGQRLRELR------------TAKGLSQETLAF-LSGLDRSYVGGVE 47

Query: 404 KIKRNLQIVGVACLALATRIEENQPY 429
           + +RN+ +V +  LA A  IE  + +
Sbjct: 48  RGQRNVSLVNILKLATALDIEPRELF 73


>pdb|2INP|A Chain A, Structure Of The Phenol Hydroxylase-Regulatory Protein
           Complex
 pdb|2INP|B Chain B, Structure Of The Phenol Hydroxylase-Regulatory Protein
           Complex
          Length = 494

 Score = 29.6 bits (65), Expect = 4.7,   Method: Compositional matrix adjust.
 Identities = 15/40 (37%), Positives = 21/40 (52%)

Query: 65  EEVIEPNETTKKIQGDEPFRRITRSYYKRQMENETKAYEV 104
           EE  E  + T   Q ++PFR    +Y+K Q E E K Y +
Sbjct: 31  EEDFEGIKITDWSQWEDPFRLTMDAYWKYQAEKEKKLYAI 70


>pdb|3U52|A Chain A, X-Ray Crystal Structure Of Xenon-Pressurized Phenol
           Hydroxylase From Pseudomonas Sp. Ox1
 pdb|3U52|B Chain B, X-Ray Crystal Structure Of Xenon-Pressurized Phenol
           Hydroxylase From Pseudomonas Sp. Ox1
          Length = 511

 Score = 29.6 bits (65), Expect = 4.7,   Method: Compositional matrix adjust.
 Identities = 15/40 (37%), Positives = 21/40 (52%)

Query: 65  EEVIEPNETTKKIQGDEPFRRITRSYYKRQMENETKAYEV 104
           EE  E  + T   Q ++PFR    +Y+K Q E E K Y +
Sbjct: 36  EEDFEGIKITDWSQWEDPFRLTMDAYWKYQAEKEKKLYAI 75


>pdb|2INN|A Chain A, Structure Of The Phenol Hydroxyalse-Regulatory Protein
           Complex
 pdb|2INN|B Chain B, Structure Of The Phenol Hydroxyalse-Regulatory Protein
           Complex
          Length = 511

 Score = 29.3 bits (64), Expect = 5.7,   Method: Compositional matrix adjust.
 Identities = 15/40 (37%), Positives = 21/40 (52%)

Query: 65  EEVIEPNETTKKIQGDEPFRRITRSYYKRQMENETKAYEV 104
           EE  E  + T   Q ++PFR    +Y+K Q E E K Y +
Sbjct: 36  EEDFEGIKITDWSQWEDPFRLTXDAYWKYQAEKEKKLYAI 75


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.315    0.130    0.372 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,259,203
Number of Sequences: 62578
Number of extensions: 477026
Number of successful extensions: 1095
Number of sequences better than 100.0: 35
Number of HSP's better than 100.0 without gapping: 4
Number of HSP's successfully gapped in prelim test: 31
Number of HSP's that attempted gapping in prelim test: 1084
Number of HSP's gapped (non-prelim): 37
length of query: 535
length of database: 14,973,337
effective HSP length: 103
effective length of query: 432
effective length of database: 8,527,803
effective search space: 3684010896
effective search space used: 3684010896
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 54 (25.4 bits)